NKCL Bio Group
Inc. (hereinafter ‘NKCL,’ Chairman Shin DongHwa) won Moneytoday 2021 Future
Creative Superiority Company Grand Award in the Innovative Immune Cell
Cultivation Technology Field for the second time in a row.
The ‘Future
Creative Superiority Company Grand Award’ was established to discover and
select companies that lead the fields of customer satisfaction excellency,
enhance the job creation, etc., along with the government’s economic policy of
Future Creative Economy.
NKCL Bio Group Inc. is a Korean bio company
that researches and develops immune cell treatment by using NK Immune Cell
based with its excellent technology. Through GMP certified automated
cultivation system, NKCL is leading popularization and mass production of 1 on
1 customized immune cell treatment.
As expanding size of bio field with
newly rising technology, Microbiome and Medifood, NKCL is applying both
technology to each field and draws synergy effect. For an example, NKCL
launched ‘NK Immune Bakery Café’ applied microbiome technology. within its
first opening of Dongtan main store in June, NK Immune Bakery café now expanded
into twenty-three stores in the whole nation and operating successfully.
In addition, an official delivered
that “By end of January of 2022, ‘NK Human Immune Treatment Center’ will be
ready its pre-open, cooperating with hospitals and clinics in Dongtan district.
In NK Human Immune Center, Immune Examination Center, Immune Treatment Center,
Immune Drug Store, Immune Café, and more will be stored. NKCL will Immune Care
Platform Service will be served and Comprehensive Treatment Plex Mall, place
where will encompass conventional and functional medicine, is on open schedule
in February.”
The official continued with
ambition, “NKCL Bio Group Inc. has been built the personalized immune care
platform, and going to focus on establishing platform ecosystem national wide
in 2022. Also in first half of 2022, ‘Global Immune Care Center’ will be open
in YeongJong-do island and is putting the best effort to attract foreign
patients who visit Korea with immune treatment purpose along with ‘with Corona’
era.”
https://news.mt.co.kr/mtview.php?no=2021112917535451564